世界のカテーテル市場2021年-2031年:製品タイプ別(心血管カテーテル、神経血管カテーテル、泌尿器カテーテル、静脈内カテーテル、特殊カテーテル)

【英語タイトル】Catheters Market By Product Type (Cardiovascular Catheters, Neurovascular Catheters, Urological Catheters, Intravenous Catheters, Specialty Catheters): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料(ALD22AU101)・商品コード:ALD22AU101
・発行会社(調査会社):Allied Market Research
・発行日:2022年5月
・ページ数:314
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥853,812見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥954,600見積依頼/購入/質問フォーム
Enterprise UserUSD10,995 ⇒換算¥1,627,260見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Allied Market Research社の当調査資料では、世界のカテーテル市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品タイプ別(心血管カテーテル、神経血管カテーテル、泌尿器カテーテル、静脈内カテーテル、特殊カテーテル)分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Abbott Laboratories、B. Braun Melsungen AG、Becton, Dickinson and Company、Boston Scientific Corporation、Johnson and Johnson、Medtronic Plc、Edwards Lifesciences Corporation、Teleflex Incorporated、Cook Medical Inc.、Stryker Corporationなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のカテーテル市場規模:製品タイプ別(心血管カテーテル、神経血管カテーテル、泌尿器カテーテル、静脈内カテーテル、特殊カテーテル)
・世界のカテーテル市場規模:地域別
・企業状況
・企業情報

Catheters are thin tubes made up of medical grade material such as plastic, silicon rubber, PVC, and nylon inserted in the patient’s body for therapeutic and diagnostic purposes. Catheterization is a primary co-procedure along with varied other medical procedures, such as angioplasty, cardiac electrophysiology, and neurosurgery. Catheters are important components in several surgical procedures.
High prevalence of cardiovascular diseases coupled with the development of unique-feature enhanced cardiovascular catheters is the core factor that drives the growth of the catheters market. Increase in prevalence of urological diseases, including urinary bladder cancer and kidney failure has significantly uplifted the demand for urological catheters. In addition, novel products,  including external male catheters have proved to be a lucrative addition to the overall catheters and variants’ product lines for the catheters manufacturing companies. Increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters—micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the growth of global catheters market. In addition, rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures fuel the market growth. However, inadequate quality assurance and price competition at domestic levels are expected to hamper the market growth. In addition, the key players such as Boston Scientific Corporation, Medtronic Plc. and Teleflex Incorporated provide catheter products contributing toward the market growth. In addition, rise in demand for catheters for the drug administration act a key driving factor for expansion of the global market.

The global catheters market is segmented on the basis of type and region. Depending on the type, the market is segmented into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters and specialty catheters. 
Cardiovascular catheter segment is classified into electrophysiology catheters, percutaneous transluminal coronary angioplasty(PTCA) balloon catheters, intravascular ultrasound(IVUS catheters), percutaneous transluminal angioplasty(PTA) catheters, and others including guiding catheter, angiography catheter, and pulmonary artery catheters. In addition, urological catheter segment is  again fragmented into dialysis catheter and urinary catheter. Dialysis catheter segment is segregated into hemodialysis catheter and  peritoneal catheter. Urinary catheter segment is  segmented into and foley catheter, intermittent catheter, and external catheters.  Furthermore, intravenous catheter segment is categorized into central intravenous catheter and peripheral intravenous catheters. Peripheral intravenous catheter segment is divided into integrated catheters and short catheters. Moreover, specialty catheter segment in classified into wound/surgical drain, oximetry, thermodilution, and IUI catheter. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the catheters market include Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corporation, Cook Medical, and Stryker Corporation.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the catheters market analysis from 2021 to 2031 to identify the prevailing catheters market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the catheters market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global catheters market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type
● Cardiovascular Catheters
● Neurovascular Catheters
● Urological Catheters
● Intravenous Catheters
● Specialty Catheters

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ U.K.
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Abbott Laboratories
○ B. Braun Melsungen AG
○ Becton, Dickinson and Company
○ Boston Scientific Corporation
○ Johnson and Johnson
○ Medtronic Plc
○ Edwards Lifesciences Corporation
○ Teleflex Incorporated
○ Cook Medical Inc.
○ Stryker Corporation

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CATHETERS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Cardiovascular Catheters
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Neurovascular Catheters
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Urological Catheters
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Intravenous Catheters
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Specialty Catheters
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
CHAPTER 5: CATHETERS MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product Type
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product Type
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product Type
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product Type
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product Type
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product Type
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Product Type
5.3.3.3 U.K.
5.3.3.3.1 Market size and forecast, by Product Type
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Product Type
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Product Type
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product Type
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product Type
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Product Type
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Product Type
5.4.3.3 India
5.4.3.3.1 Market size and forecast, by Product Type
5.4.3.4 Australia
5.4.3.4.1 Market size and forecast, by Product Type
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Product Type
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Product Type
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product Type
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product Type
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product Type
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Product Type
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Product Type
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 B. Braun Melsungen AG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Becton, Dickinson and Company
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Boston Scientific Corporation
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Johnson and Johnson
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Medtronic Plc
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Edwards Lifesciences Corporation
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Teleflex Incorporated
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Cook Medical Inc.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 Stryker Corporation
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 2. CATHETERS MARKET REVENUE, FOR CARDIOVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 3. CATHETERS MARKET FOR CARDIOVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. CATHETERS MARKET REVENUE, FOR NEUROVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 5. CATHETERS MARKET FOR NEUROVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. CATHETERS MARKET REVENUE, FOR UROLOGICAL CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 7. CATHETERS MARKET FOR UROLOGICAL CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 8. CATHETERS MARKET REVENUE, FOR INTRAVENOUS CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 9. CATHETERS MARKET FOR INTRAVENOUS CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 10. CATHETERS MARKET REVENUE, FOR SPECIALTY CATHETERS, BY REGION , 2021-2031,($MILLION)
TABLE 11. CATHETERS MARKET FOR SPECIALTY CATHETERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 12. CATHETERS MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 13. NORTH AMERICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 14. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 15. U.S. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 16. CANADA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 17. MEXICO CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 18. EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 19. EUROPE CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 20. GERMANY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 21. FRANCE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 22. U.K. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 23. ITALY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 24. SPAIN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 25. REST OF EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 26. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 27. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 28. JAPAN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 29. CHINA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 30. INDIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 31. AUSTRALIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 32. SOUTH KOREA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 33. REST OF ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 34. LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 35. LAMEA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 36. BRAZIL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 37. SAUDI ARABIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 38. SOUTH AFRICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 39. REST OF LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 40.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 41.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 42.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 43.ABBOTT LABORATORIES: NET SALES,
TABLE 44.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 45.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 46.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 47.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 48.B. BRAUN MELSUNGEN AG: NET SALES,
TABLE 49.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
TABLE 50.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 51.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 52.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 53.BECTON, DICKINSON AND COMPANY: NET SALES,
TABLE 54.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 55.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 56.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 57.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 58.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 59.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 60.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 61.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 62.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 63.JOHNSON AND JOHNSON: NET SALES,
TABLE 64.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 65.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 66.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 67.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 68.MEDTRONIC PLC: NET SALES,
TABLE 69.MEDTRONIC PLC: KEY STRATERGIES
TABLE 70.EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 71.EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 72.EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 73.EDWARDS LIFESCIENCES CORPORATION: NET SALES,
TABLE 74.EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES
TABLE 75.TELEFLEX INCORPORATED: COMPANY SNAPSHOT
TABLE 76.TELEFLEX INCORPORATED: OPERATING SEGMENTS
TABLE 77.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
TABLE 78.TELEFLEX INCORPORATED: NET SALES,
TABLE 79.TELEFLEX INCORPORATED: KEY STRATERGIES
TABLE 80.COOK MEDICAL INC.: COMPANY SNAPSHOT
TABLE 81.COOK MEDICAL INC.: OPERATING SEGMENTS
TABLE 82.COOK MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 83.COOK MEDICAL INC.: NET SALES,
TABLE 84.COOK MEDICAL INC.: KEY STRATERGIES
TABLE 85.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 86.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 87.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 88.STRYKER CORPORATION: NET SALES,
TABLE 89.STRYKER CORPORATION: KEY STRATERGIES

★調査レポート[世界のカテーテル市場2021年-2031年:製品タイプ別(心血管カテーテル、神経血管カテーテル、泌尿器カテーテル、静脈内カテーテル、特殊カテーテル)] (コード:ALD22AU101)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のカテーテル市場2021年-2031年:製品タイプ別(心血管カテーテル、神経血管カテーテル、泌尿器カテーテル、静脈内カテーテル、特殊カテーテル)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆